An expert discusses strategies for monitoring response to treatment, including observation, Epstein-Barr virus (EBV) titers, ...
16 天
GlobalData on MSNImunon reports immunogenicity and safety data from DNA plasmid vaccine trialImunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The investigational vaccine, based on the company ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果